MicroRNAs May Underlie Endometriosis
A new study of human cells suggests that a pair of microRNAs regulates expression of a transcription factor that goes haywire in women with endometriosis.
Homeobox A10 (HOXA10) regulates receptivity of the endometrium to implantation and controls expression of various cell adhesion molecules, signal transduction factors, and other molecules. Under the control of sex steroids, HOXA10 is expressed cyclically during the menstrual cycle, with expression peaking during the window of implantation.
The endometrium of women with endometriosis and other implantation disorders shows reduced expression of HOXA10. This defect may underlie the decreased receptivity of the endometrium to embryo implantation that often afflicts women with endometriosis.
Sex steroid levels are not affected in women with endometriosis and so do not account for decreased HOXA10 expression; Rafaella Petracco et al. searched for an alternative culprit. They employed bioinformatics software to predict which microRNAs might regulate the HOXA10 gene and landed on MIR135A and MIR135B.
The researchers found that both microRNAs are expressed in a pattern that suggests a role in HOXA10 regulation. They are both expressed in the endometrium of healthy women and MIR135A is expressed cyclically, peaking when HOXA10 levels are lowest. Expression of both microRNAs is elevated in women with endometriosis, most dramatically during the proliferative phase of the cycle, when HOXA10 expression is low.
These correlative studies were supported by transfection experiments using endometrial cells, which showed that the two microRNAs regulate HOXA10. The microRNAs reduced expression of a luciferase gene hooked to the HOXA10 3 0 UTR in endometrial stromal cells, but did not reduce reporter expression in an unrelated cell type, MCF-7 cells. The data suggest that MIR135A and MIR135B operate in context with other factors found specifically in endometrial cells.
The findings reveal a new potential therapeutic target for endometriosis, a difficult-to-treat and poorly understood condition. The enzyme DICER1 is essential for the biogenesis of several small classes of RNAs, including microRNAs (miRNAs) and endogenous small interfering RNAs (endo-siRNAs), both of which have been implicated in numerous biological processes. Dicer 1 is also essential for degrading toxic transposable elements.
Previously, two groups of researchers had knocked out DICER1 in the male germline using Cre recombinase-expressing mice. The mice had had impaired fertility due to defects such as poor sperm motility. But the authors of the new study, Yannick Romero et al., say that DICER1 may not have been completely knocked out in these studies-for instance, Cre was hooked up to a promoter that drove its expression in only about half of all male germ cells. Romero et al. knocked DICER1 out cold by driving Cre with a different promoter, that for the germline factor DDX4 (also known as Vasa).
The researchers found that DICER1 was not required for spermatogonial stem cell renewal and mitotic proliferation, but the enzyme was required for meiosis, with defects emerging prior to prophase I and the haploid stage of spermatogenesis. Alterations included delayed progression of meiotic prophase I and an increase in apoptosis in spermatocytes. The few spermatids found in the mice had various defects, such as abnormal head shape and immotility. Dicer1-depleted spermatocytes also showed upregulated expression of retrotransposons in the short interspersed elements (SINE) family.
Whether the defects are due to SINE upregulation or to defects in miRNA or endo-siRNA processing are unclear. Previous studies have found that spermatogenic cells express numerous classes of small noncoding RNAs and that one of these, MIR21, seems to fend off apoptosis in spermatogonial stem cells. 
Rapamycin Prevents Preterm Birth in Mouse Model
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Each year, nearly 13 million preterm births occur worldwide, with serious repercussions for both mothers and infants; yet the mechanisms for this condition are poorly understood. New research shows that a single administration of the common drug rapamycin prevents preterm birth in a mouse model, implicating the rapamycin target mTORC1 (mammalian target of rapamycin complex 1) in the condition.
S.K. Dey and colleagues had previously created a model of preterm birth by genetically deleting the tumor suppressor Trp53 (also known as p53) in endometrial cells of the uterus. The researchers found that the uterine decidual cells in these mice underwent premature terminal differentiation and cellular senescence, but the molecular events leading to these effects were not fully examined.
The researchers now report that mTORC1 signaling is turned on in decidual cells of the p53-deficient mice, and activation of this intracellular pathway promotes cellular senescence. Remarkably, a single administration of rapamycin both reduced cellular senescence and reversed preterm birth in these mice. Cellular senescence also gradually increases in the decidua of pregnant wild-type mice in the days prior to parturition.
The researchers provide evidence that mTORC1 promotes senescence, which in turn prompts an increase in expression of cyclooxygenase-2 (COX-2, official symbol PTGS2), an enzyme previously shown to be upregulated in the mouse model. COX-2 bumps up production of prostaglandins known to participate in parturition, and COX-2 inhibitors can also restore normal timing of birth in the model.
The findings bolster the notion that cellular senescence may help trigger physiologically normal birth and that early activation of senescence may induce preterm birth. The findings could also possibly help explain the association between increased maternal age and adverse perinatal outcome, including preterm birth.
The March of Dimes has designated November as Prematurity Awareness Month.
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